홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Doxifluridine

HCID 18343
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
3094-09-5
표준 SMILES
C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O
InChIKey
ZWAOHEXOSAUJHY-ZIYNGMLESA-N
분자식
C9H11FN2O5
평균 분자량
246.19 g/mol
단동위원소 질량
246.06519962

개요

Doxifluridine is a pyrimidine 5'-deoxyribonucleoside that is 5-fluorouridine in which the hydroxy group at the 5' position is replaced by a hydrogen. It is an oral prodrug of the antineoplastic agent 5-fluorouracil. Designed to circumvent the rapid degradation of 5-fluorouracil by dihydropyrimidine dehydrogenase in the gut wall, it is converted into 5-fluorouracil in the presence of pyrimidine nucleoside phosphorylase. It has a role as an antimetabolite, an antineoplastic agent and a prodrug. It is an organofluorine compound and a pyrimidine 5'-deoxyribonucleoside.

이름 및 식별자

우선 이름
Doxifluridine
IUPAC
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione
영어명
Doxifluridine
분자식
C9H11FN2O5
분자량
246.19

이름 및 동의어

doxifluridine5'-Deoxy-5-fluorouridine5-fluoro-5'-deoxyuridineFurtulon3094-09-5Uridine, 5'-deoxy-5-fluoro-Flutron5'-DfurDoxifluridinaDoxifluridinumFulturonRo 219738
이름 더 보기
5'DFURDAMC 01015-F-5‘-dURO-21-97385-cl-5'-dUDoxifluidine
DTXSID2022967Uridine-5'-deoxy-5-fluoro-1-(beta-D-5-Desoxyribofuranoxyl)-5-fluoruracilRo 21-97385-DFURV1JK16Y2JPNSC-758890RO-219738

데이터베이스 식별자

CAS
3094-09-5
PubChem CID
18343
DTXSID
DTXSID2022967
ChEMBL
CHEMBL1130
ChEBI
CHEBI:31521
UNII
V1JK16Y2JP
EC Number
221-440-1
Nikkaji
J7.679A

물성

구조 계산 물성

XLogP
-1.7
극성 표면적
99.1 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
6
회전 가능 결합 수
1
무거운 원자 수
17
형식 전하
0
복잡도
399

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antineoplastic and immunomodulating agents -> Antineoplastic agents

Solubility>36.9 [ug/mL] (The mean of the results at pH 7.4)
Collision Cross Section150.41 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
188 · 188-192 °C(lit.)
밀도
1.3751 · 1.3751 (estimate)
굴절률
20 ° · 20 ° (C=1, H2O)
저장 조건
Inert atmosphere,Room Temperature
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
7.4 · 7.4(at 25℃)
색상
하얀색
Merck
14 · 14,3437
주요 응용
소분자 약용
InChI
InChI=1S/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3-,5-,6-,8-/m1/s1

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 16.7% (1 of 6) of reports.

Danger

H226 (16.7%): Flammable liquid and vapor [Warning Flammable liquids]

P203, P210, P233, P240, P241, P242, P243, P261, P264, P264+P265, P271, P272, P273, P280, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P317, P318, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P370+P378, P391, P403+P233, P403+P235, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 6 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesFlam. Liq. 3 (16.7%)

독성 정보

Drug Induced Liver Injury · 4건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Doxifluridine

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

안전 데이터

wgk
2
rtecs
YU7526000
독성
LD50 (14 day) in mice or rats (mg/kg): >1000 i.v.: >2000 s.c.; in male, female mice, male, female rats (mg/kg): >5000, >5000, 3471, 3390 orally (Shimizu)
HS 번호
29349990
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36-24/25
위험 등급
IRRITANT, IRRITANT-HARMFUL

화학 및 산업

약리 정보

MeSH Pharmacological Classification · 3건

Antimetabolites that are useful in cancer chemotherapy.

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS.

Tissue LocationsKidney
Cellular LocationsCytoplasm
Metabolite PathwaysCapecitabine Action Pathway

응용 분야

개요Doxifluridine is a prodrug derivative of 5-fluorouracil (5-FU). As an antineoplastic it is more potent than 5-FU in the treatment of breast, stomach, colon and rectal cancers.

용도An antitumor agent efficient in tumors, cell lines or in fibroblasts tranformed by H-ras or trk oncogenes. A metabolite of Capecitabine

상·하류 제품 정보

상류 원료

Palladium carbon fine chemical catalyzerp-토루엔 술폰산 일수화물초산에틸트리페닐스티빈

관련 반응

8건
반응 기록 만들기
HRID 1089416 반응식
HRID 1089416반응물로
HRID 1358063 반응식
HRID 1358063생성물로
HRID 1358065 반응식
HRID 1358065생성물로
HRID 1358067 반응식
HRID 1358067생성물로
HRID 1719780 반응식
HRID 1719780생성물로
HRID 1759378 반응식
HRID 1759378생성물로
HRID 1759379 반응식
HRID 1759379생성물로
HRID 2091456 반응식
HRID 2091456반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
InChIKey
ZWAOHEXOSAUJHY-ZIYNGMLESA-N
SMILES
C[C@H]1O[C@@H](N2C=C(F)C(=O)NC2=O)[C@H](O)[C@@H]1O

화학적 성질

White Solid

위험 참고 사항
Irritant
스토리지 클래스
11 - Combustible Solids
요오드 메탄
2,2-디메폭시프로판
추가 설명 · 1건

정의ChEBI: A pyrimidine 5'-deoxyribonucleoside that is 5-fluorouridine in which the hydroxy group at the 5' position is replaced by a hydrogen. It is an oral prodrug of the antineoplastic agent 5-fluorouracil. Designed to circumvent the rapid degradation of 5-fluoro racil by dihydropyrimidine dehydrogenase in the gut wall, it is converted into 5-fluorouracil in the presence of pyrimidine nucleoside phosphorylase.